Vitamin D and Immune Function: A Comprehensive Review of the Clinical Evidence
Last reviewed: 21 de marzo de 2026 a las 07:02
Vitamin D has emerged as one of the most intensively studied nutrients in immunology over the past two decades, driven by the discovery that virtually every cell type in the immune system expresses the vitamin D receptor (VDR) and that immune cells can locally convert circulating 25-hydroxyvitamin D into its active hormonal form, 1,25-dihydroxyvitamin D. This active metabolite influences the expression of over 200 genes involved in immune regulation, including genes that encode antimicrobial peptides such as cathelicidin and defensins, which serve as the body's natural antibiotics against bacteria, viruses, and fungi. Vitamin D also appears to modulate the balance between pro-inflammatory and anti-inflammatory immune responses, enhancing innate immunity while dampening excessive adaptive immune activation. These mechanistic insights have generated enormous interest in whether vitamin D supplementation can translate into meaningful clinical benefits for immune-related conditions.
The most robust clinical evidence for vitamin D and immunity comes from research on acute respiratory tract infections (ARTIs). A landmark individual participant data meta-analysis published in the BMJ in 2017, encompassing 25 randomized controlled trials and over 11,000 participants, concluded that vitamin D supplementation reduced the overall risk of acute respiratory infections by approximately 12%. The protective effect was most pronounced in individuals who were vitamin D deficient at baseline — those with serum 25(OH)D levels below 25 nmol/L experienced a 70% reduction in risk with supplementation. The analysis also found that daily or weekly dosing was more effective than large intermittent bolus doses, suggesting that maintaining steady circulating levels is important for immune protection. A subsequent updated meta-analysis in 2021, including additional trials, confirmed these findings and extended the evidence to suggest benefits across a broader range of baseline vitamin D levels.
Beyond respiratory infections, vitamin D has been studied for its potential role in autoimmune disease prevention. The VITAL study, a large randomized controlled trial of over 25,000 participants followed for more than five years, found that vitamin D supplementation at 2,000 IU daily was associated with a 22% reduction in confirmed autoimmune diseases, including rheumatoid arthritis, polymyalgia rheumatica, psoriasis, and autoimmune thyroid disease. This finding is consistent with the mechanistic understanding that vitamin D promotes regulatory T cells, which help maintain immune tolerance and prevent the immune system from attacking the body's own tissues. Observational studies have also noted higher rates of autoimmune conditions in populations living at higher latitudes where sun exposure and vitamin D synthesis are reduced, though such ecological associations cannot establish causation. The interplay between vitamins D and A is also an area of active investigation, as both nutrients signal through nuclear receptors that may interact in regulating immune cell differentiation.
Determining optimal vitamin D levels for immune function remains an active area of debate among researchers. Most clinical guidelines define deficiency as a serum 25-hydroxyvitamin D level below 20 ng/mL (50 nmol/L) and insufficiency as 20-29 ng/mL, but some immunologists argue that levels of 40-60 ng/mL may be more optimal for immune function based on the dose-response data from supplementation trials. The Endocrine Society recommends 1,500-2,000 IU daily for most adults to maintain adequate levels, though individuals with obesity, malabsorption syndromes, or limited sun exposure may require higher doses. It is worth noting that vitamin D is fat-soluble and can accumulate to toxic levels with excessive supplementation, so testing serum levels before and during high-dose supplementation is advisable. Omega-3 fatty acids, which were co-administered with vitamin D in the VITAL trial, may also support immune regulation through their effects on resolving inflammation, and the combination of these nutrients is an area of growing research interest.
The most robust clinical evidence for vitamin D and immunity comes from research on acute respiratory tract infections (ARTIs). A landmark individual participant data meta-analysis published in the BMJ in 2017, encompassing 25 randomized controlled trials and over 11,000 participants, concluded that vitamin D supplementation reduced the overall risk of acute respiratory infections by approximately 12%. The protective effect was most pronounced in individuals who were vitamin D deficient at baseline — those with serum 25(OH)D levels below 25 nmol/L experienced a 70% reduction in risk with supplementation. The analysis also found that daily or weekly dosing was more effective than large intermittent bolus doses, suggesting that maintaining steady circulating levels is important for immune protection. A subsequent updated meta-analysis in 2021, including additional trials, confirmed these findings and extended the evidence to suggest benefits across a broader range of baseline vitamin D levels.
Beyond respiratory infections, vitamin D has been studied for its potential role in autoimmune disease prevention. The VITAL study, a large randomized controlled trial of over 25,000 participants followed for more than five years, found that vitamin D supplementation at 2,000 IU daily was associated with a 22% reduction in confirmed autoimmune diseases, including rheumatoid arthritis, polymyalgia rheumatica, psoriasis, and autoimmune thyroid disease. This finding is consistent with the mechanistic understanding that vitamin D promotes regulatory T cells, which help maintain immune tolerance and prevent the immune system from attacking the body's own tissues. Observational studies have also noted higher rates of autoimmune conditions in populations living at higher latitudes where sun exposure and vitamin D synthesis are reduced, though such ecological associations cannot establish causation. The interplay between vitamins D and A is also an area of active investigation, as both nutrients signal through nuclear receptors that may interact in regulating immune cell differentiation.
Determining optimal vitamin D levels for immune function remains an active area of debate among researchers. Most clinical guidelines define deficiency as a serum 25-hydroxyvitamin D level below 20 ng/mL (50 nmol/L) and insufficiency as 20-29 ng/mL, but some immunologists argue that levels of 40-60 ng/mL may be more optimal for immune function based on the dose-response data from supplementation trials. The Endocrine Society recommends 1,500-2,000 IU daily for most adults to maintain adequate levels, though individuals with obesity, malabsorption syndromes, or limited sun exposure may require higher doses. It is worth noting that vitamin D is fat-soluble and can accumulate to toxic levels with excessive supplementation, so testing serum levels before and during high-dose supplementation is advisable. Omega-3 fatty acids, which were co-administered with vitamin D in the VITAL trial, may also support immune regulation through their effects on resolving inflammation, and the combination of these nutrients is an area of growing research interest.